Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mersana Therapeutics Inc (MRSN)

Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 241,051
  • Shares Outstanding, K 122,361
  • Annual Sales, $ 36,860 K
  • Annual Income, $ -171,670 K
  • 60-Month Beta 1.54
  • Price/Sales 7.14
  • Price/Cash Flow N/A
  • Price/Book 9.32
Trade MRSN with:

Options Overview Details

View History
  • Implied Volatility 141.23% ( +24.31%)
  • Historical Volatility 57.85%
  • IV Percentile 75%
  • IV Rank 16.82%
  • IV High 605.76% on 11/16/23
  • IV Low 47.27% on 11/09/23
  • Put/Call Vol Ratio 41.00
  • Today's Volume 42
  • Volume Avg (30-Day) 42
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 15,586
  • Open Int (30-Day) 15,359

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.18
  • Number of Estimates 4
  • High Estimate -0.14
  • Low Estimate -0.25
  • Prior Year -0.47
  • Growth Rate Est. (year over year) +61.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7600 +11.93%
on 07/05/24
2.2900 -13.97%
on 07/17/24
-0.0700 (-3.43%)
since 06/18/24
3-Month
1.7600 +11.93%
on 07/05/24
3.6300 -45.73%
on 05/07/24
-1.2800 (-39.38%)
since 04/19/24
52-Week
0.8014 +145.82%
on 07/27/23
6.2801 -68.63%
on 03/11/24
-1.7900 (-47.61%)
since 07/19/23

Most Recent Stories

More News
1 'Strong Buy' Russell 2000 Stock With 188% Upside Potential

As a part of the annual Russell Index reconstitution, this ‘Strong Buy’-rated penny stock is one of the new entrants to the Russell 2000 Index.

ADCT : 3.44 (-6.27%)
$SPX : 5,505.00 (-0.71%)
MRSN : 1.9700 (-8.37%)
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

DTC.CN : 0.8900 (-2.20%)
MGNX : 4.92 (-1.99%)
IOVA : 7.96 (-4.21%)
MRTX : 58.70 (-0.17%)
MRSN : 1.9700 (-8.37%)
DTCFF : 0.6607 (+8.13%)
LLY : 857.47 (+1.01%)
PFE : 29.97 (+0.88%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.9700 (-8.37%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.9700 (-8.37%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.9700 (-8.37%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.9700 (-8.37%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.9700 (-8.37%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.9700 (-8.37%)
MRSN NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Mersana Therapeutics, Inc.

/PRNewswire/ -- The Klein Law Firm announces that it is investigating allegations that Mersana Therapeutics, Inc. ("Mersana") (NASDAQ: MRSN) violated federal...

MRSN : 1.9700 (-8.37%)
MRSN ALERT: The Law Offices of Vincent Wong Investigate Mersana Therapeutics, Inc. for Potential Violations of Securities Laws

/PRNewswire/ -- Attention Mersana Therapeutics, Inc. ("Mersana") (NASDAQ: MRSN) shareholders: The Law Offices of Vincent Wong announce that an investigation...

MRSN : 1.9700 (-8.37%)

Business Summary

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

See More

Key Turning Points

3rd Resistance Point 2.3967
2nd Resistance Point 2.2833
1st Resistance Point 2.1267
Last Price 1.9700
1st Support Level 1.8567
2nd Support Level 1.7433
3rd Support Level 1.5867

See More

52-Week High 6.2801
Fibonacci 61.8% 4.1872
Fibonacci 50% 3.5408
Fibonacci 38.2% 2.8943
Last Price 1.9700
52-Week Low 0.8014

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar